The board of directors governing Corbus Pharmaceuticals includes experienced biotechnology executives, independent industry veterans, and corporate leaders. Key members include Rachelle Jacques (serving as Chair of the Board) alongside expert directors like pharmaceutical veteran Dr. Brent Pfeiffenberger, Chief Executive Officer Dr. Yuval Cohen, and other independent industry leaders who oversee corporate governance, audit standards, and strategic clinical milestones.